Bragar Eagel &amp; Squire, P.C. Litigation Partner Brandon Walker Encourages Investors Who Suffered Losses In Telix ( TLX ) To Contact Him Directly To Discuss Their Options

<p>Bragar Eagel & Squire, P.C. 正在代表其股东调查 Telix Pharmaceuticals Limited，原因是可能违反联邦证券法。此次调查是在 Telix 披露了来自 SEC 的传票后进行的，该传票涉及其前列腺癌治疗候选药物，这导致其 ADR 价格下跌了 10.44%。遭受损失的投资者被鼓励联系该公司以寻求法律选项</p>

TELIX ALERT: Bragar Eagel & Squire, P.C. is Investigating Telix Pharmaceuticals Limited on Behalf of Telix Stockholders and Encourages Investors to Contact the Firm

TELIX 警报：Bragar Eagel & Squire, P.C. 正在代表 Telix Pharmaceuticals 的股东进行调查，并鼓励投资者与该律所联系